CTNM
NASDAQ · Pharmaceuticals
Contineum Therapeutics Inc-A
$13.53
+0.32 (+2.42%)
Open$13.23
Previous Close$13.21
Day High$13.89
Day Low$13.15
52W High$17.79
52W Low$8.60
Volume—
Avg Volume442.0K
Market Cap509.01M
P/E Ratio—
EPS$-1.74
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
+186.9% upside
Current
$13.53
$13.53
Target
$38.82
$38.82
$27.95
$38.82 avg
$46.43
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 273.32M | 248.64M | 220.16M |
| Net Income | 33.71M | 25.85M | 22.01M |
| Profit Margin | 12.3% | 10.4% | 10.0% |
| EBITDA | 45.63M | 48.42M | 37.59M |
| Free Cash Flow | 26.06M | 26.05M | 25.67M |
| Rev Growth | -0.8% | +22.0% | +2.7% |
| Debt/Equity | 0.64 | 0.69 | 0.58 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |